Analysis of Shigella flexneri-mediated infections in model organism Caenorhabditis elegans

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 4, 2011, Pages 286-295

  Kesika, Periyanaina ^a   Karutha Pandian, Shunmugiah ^a   Balamurugan, Krishnaswamy ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Caenorhabditis elegans; gene expression; innate immunity; pathogenesis; Shigella

Indexed keywords

LECTIN; LYSOZYME; MESSENGER RNA; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HOST PARASITE INTERACTION; INNATE IMMUNITY; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PROGENY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHIGELLA FLEXNERI; SHIGELLOSIS;

ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; LECTINS; MURAMIDASE; SHIGELLA FLEXNERI; VIRULENCE FACTORS;

EID: 79952647590     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.548400     Document Type: Article

References (43)

1. Gravato-Nobre MJ, Hodgkin J. Caenorhabditis elegans as a model for innate immunity to pathogens. Cell Microbiol 2005;7:741-51. (Pubitemid 40740371)
2. Sifri CD, Begun J, Ausubel FM, Calderwood SB. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun 2003;71:2208-17. (Pubitemid 36368756)
3. Molinaro A, Silipo A, Castro C.D, Sturiale L, Nigro G, Garozzo D, et al. Full structural characterization of Shigella fl exneri M90T serotype 5 wild-type R-LPS and its ffgalU mutant: glycine residue location in the inner core of the lipopolysaccharide. Glycobiology 2008;18:260-9. (Pubitemid 351359693)
4. Tiruneh M. Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia. Jpn J Infect Dis 2009;62: 93-7.
5. Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008;21:134-56. (Pubitemid 351160013)
6. McCormick BA, Siber AM, Maurelli AT. Requirement of the Shigella fl exneri virulence plasmid in the ability to induce traffi cking of neutrophils across polarized monolayers of the intestinal epithelium. Infect Immun 1998;66:4237-43. (Pubitemid 28402697)
7. Sakaguchi T, Kohler H, Gu X, McCormick BA, Reinecker HC. Shigella fl exneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol 2002;4:367-81. (Pubitemid 34727540)
8. Phalipon A, Sansonetti PJ. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 2007;85:119-29. (Pubitemid 46398723)
9. Green J, Baldwin ML. The molecular basis for the differential regulation of the hlyE-encoded haemolysin of Escherichia coli by FNR and HlyX lies in the improved activating region 1 contact of HlyX. Microbiology 1997;143:3785-93. (Pubitemid 28004611)
10. Ludwig A, Bauer S, Benz R, Bergmann B, Goebel W. Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol 1999;31: 557-67. (Pubitemid 29046097)
11. Oscarsson J, Mizunoe Y, Li L, Lai XH, Weislander A, Uhlin BE. Molecular analysis of the cytolytic protein ClyA (SheA) from Escherichia coli. Mol Microbiol 1999;32:1226-38. (Pubitemid 29286662)
12. Wallace AJ, Stillman TJ, Atkins A, Jamieson SJ, Bullough PA, Green J, et al. E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell 2000;100:265-76. (Pubitemid 30064914)
13. Hunt S, Moir AJ, Tzokov S, Bullough PA, Artymiuk PJ, Green J. The formation and structure of Escherichia coli K-12 haemolysin E pores. Microbiology 2008;154:633-42. (Pubitemid 351292316)
14. Hunt S, Green J, Artymiuk PJ. Hemolysin E (HlyE, ClyA, SheA) and related toxins. Adv Exp Med Biol 2010;677: 116-26.
15. Burton EA, Pendergast AM, Aballay A. The Caenorhabditis elegans ABL-1 tyrosine kinase is required for Shigella fl exneri pathogenesis. Appl Environ Microbiol 2006;72:5043-51. (Pubitemid 44078837)
16. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, et al. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA 2001;98:10892-7. (Pubitemid 32878715)
17. Aballay A, Ausubel FM. Programmed cell death mediated by ced -3 and ced -4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc Natl Acad Sci USA 2001;98:2735-9. (Pubitemid 32209552)
18. Labrousse A, Chauvet S, Couillault C, Kurz CL, Ewbank JJ. Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr Biol 2000;10:1543-5. (Pubitemid 32003650)
19. Mallo GV, Kurz CL, Couillault C, Pujol N, Granjeaud S, Kohara Y, et al. Inducible antibacterial defense system in C. elegans. Curr Biol 2002;12:1209-14. (Pubitemid 34801168)
20. Couillault C, Ewbank JJ. Diverse bacteria are pathogens of Caenorhabditis elegans. Infect Immun 2002;70:4705-7. (Pubitemid 34790988)
21. Darby C, Hsu JW, Ghori N, Falkow S. Caenorhabditis elegans: plague bacteria biofi lm blocks food intake. Nature 2002;417:243-4. (Pubitemid 34534698)
22. O'R ourke D, Baban D, Demidova M, Mott R, Hodgkin J. Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res 2006;16: 1005-16. (Pubitemid 44162260)
23. Joshua GW, Karlyshev AV, Smith MP, Isherwood KE, Titball RW, Wren BW. A Caenorhabditis elegans model of Yersinia infection: biofi lm formation on a biotic surface. Microbiology 2003;149:3221-9. (Pubitemid 37442005)
24. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002;297: 623-6. (Pubitemid 34815350)
25. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Natl Acad Sci U S A 2004;101:10995-1000. (Pubitemid 38989573)
26. Nicholas HR, Hodgkin J. The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr Biol 2004;14:1256-61. (Pubitemid 38991812)
27. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 2003;300:1921. (Pubitemid 36734593)
28. Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS J 2005;272:6179-217. (Pubitemid 41815610)
29. Wong D, Bazopoulou D, Pujol N, Tavernarakis N, Ewbank JJ. Genome-wide investigation reveals pathogen-specifi c and shared signatures in the response of Caenorhabditis elegans to infection. Genome Biol 2007;8:R194.
30. Leippe M. Antimicrobial and cytolytic polypeptides of amoeboid protozoa-effector molecules of primitive phagocytes. Dev Comp Immunol 1999;23:267-79. (Pubitemid 29309606)
31. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2006;2:e183.
32. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA. Specifi city and complexity of the Caenorhabditis elegans innate immune response. Mol Cell Biol 2007;27:5544-53. (Pubitemid 47124406)
33. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974;77:71-94.
34. Jain C, Yun M, Politz SM, Rao RP. A pathogenesis assay using Saccharomyces cerevisiae and Caenorhabditis elegans reveals novel roles for yeast AP-1, Yap1, and host dual oxidase BLI-3 in fungal pathogenesis. Eukaryot Cell 2009;8:1218-27.
35. Shtonda BB, Avery L. Dietary choice behavior in Caenorhabditis elegans. J Exp Biol 2006;209:89-102. (Pubitemid 43163667)
36. Zhang Y, Lu H, Bargmann CI. Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 2005;438:179-84. (Pubitemid 41599864)
37. Ogawa M, Sasakawa C. Shigella and autophagy. Autophagy 2006;2:171-4. (Pubitemid 44030879)
38. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989;159:1126-8. (Pubitemid 19138818)
39. Festing MP, Baumans V, Combas DR, Halder M, Hendriksen FM, Howard BP, et al. Reducing the use of laboratory animals in biomedical research: problems and possible solution. Altern Lab Anim 1998;26:283-301.
40. Shashikumar S, Rajini PS. Cypermethrin-induced alterations in vital physiological parameters and oxidative balance in Caenorhabditis elegans. Pestic Biochem Physiol 2010;97: 235-42.
41. Drickamer K, Dodd RB. C-Type lectin-like domains in Caenorhabditis elegans: predictions from the complete genome sequence. Glycobiology 1999;9:1357-69. (Pubitemid 30011516)
42. Nicholas HR, Hodgkin J. Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans. Mol Immunol 2004;41:479-93. (Pubitemid 38746658)
43. Sperandio B, Regnault B, Guo J, Zhang Z, Stanley Jr SL, Sansonetti PJ, et al. Virulent Shigella fl exneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med 2008; 205:1121-32. (Pubitemid 351679687)